GGrantIndex
← Search

Mayo CCCG (Supp) - Impact of Multi-Channel Communication Campaigns on Cancer Prevention, Control and Survivorship (CaPCaS) in Black, Hispanic, Rural, and Sexual and Gender Minority Populations

$200,000P30FY2024CANIH

Mayo Clinic Rochester, Rochester MN

Investigators

Linked publications, trials & patents

Trial NCT06508463Trial NCT06387979Trial NCT06381154Trial NCT06353191Trial NCT06315595Trial NCT06271291Trial NCT06238648Trial NCT06207188Trial NCT06160206Trial NCT06115772Trial NCT06078709Trial NCT06075524Trial NCT06073951Trial NCT06058663Trial NCT05917145Trial NCT05910801Trial NCT05720624Trial NCT05717153Trial NCT05704283Trial NCT05703399Trial NCT05674123Trial NCT05653661Trial NCT05640765Trial NCT05612100Trial NCT05591092Trial NCT05584449Trial NCT05575440Trial NCT05560009Trial NCT05557877Trial NCT05556525Trial NCT05549661Trial NCT05547386Trial NCT05547347Trial NCT05541016Trial NCT05530759Trial NCT05526417Trial NCT05523154Trial NCT05518903Trial NCT05512767Trial NCT05507879Trial NCT05507541Trial NCT05497804Trial NCT05465954Trial NCT05465941Trial NCT05447923Trial NCT05447910Trial NCT05443971Trial NCT05438563Trial NCT05417867Trial NCT05416983Trial NCT05412953Trial NCT05411523Trial NCT05411497Trial NCT05410977Trial NCT05407038Trial NCT05407025Trial NCT05403580Trial NCT05399004Trial NCT05393713Trial NCT05392946Trial NCT05388877Trial NCT05388851Trial NCT05388058Trial NCT05388006Trial NCT05356897Trial NCT05294367Trial NCT05288062Trial NCT05269381Trial NCT05246670Trial NCT05232851Trial NCT05224271Trial NCT05222620Trial NCT05212428Trial NCT05199285Trial NCT05194293Trial NCT05176223Trial NCT05168163Trial NCT05130060Trial NCT05112627Trial NCT05112614Trial NCT05111314Trial NCT05077735Trial NCT05075980Trial NCT05053100Trial NCT05045066Trial NCT05033288Trial NCT05030298Trial NCT05018208Trial NCT05005182Trial NCT04999826Trial NCT04975516Trial NCT04967196Trial NCT04926948Trial NCT04925817Trial NCT04917744Trial NCT04906369Trial NCT04897009Trial NCT04895735Trial NCT04892277Trial NCT04892264

Abstract

ABSTRACT This application is being submitted by the Mayo Clinic Comprehensive Cancer Center (MCCCC) to extend the period of support for the P30 Administrative Supplement for Multi-Channel Communication Campaigns for Improvements in Cancer Education and Outcomes (MICEO) in Underserved Populations. The MICEO program will continue to be coordinated by the MCCCC Community Outreach & Engagement (COE) Office and Programs in three MCCCC catchment areas (CAs): Arizona (AZ), Florida (FL), and the Midwest/Mayo Clinic Health Systems (MCHS). The MICEO extension builds on the significant progress made through the initial MICEO funding period. As of June 2024, our reach includes 100+ Hispanic adults in Arizona (AZ) CA, 500+ Black men in Florida (FL) CA, and 100+ rural adults in the Midwest/MCHS CA. We developed and published the Cancer Advocacy Handbook in both English and Spanish, with a total of 25 community health educators (CHEs) trained. Additionally, 25 advocates from other Cancer Centers were trained during the Science of COE Conference, co- organized by the MCCCC. Focusing on colorectal, liver, lung, and prostate cancers, multi-channel communication activities were provided to at least 1,000+ general population aged 30 years and above across the cancer care continuum. The distribution channels employed included print media, virtual tools (including the Mayo Clinic Connect platform), and both virtual and hybrid events and meetings (cancer conversations), as well as interpersonal communications (Health Fairs, Farmers Markets, Churches). The primary goal of the initial (ongoing) supplement was to assess the impact of multi-channel communication campaigns targeting Black, Hispanic, and Rural populations on cancer prevention, control, and survivorship (CaPCaS). The proposed supplement extension project will continue to focus on Track 2, targeting the general population aged 30 years and above. Specifically, the extension will continue efforts for the implementation, sustainability, and evaluation of the MICEO initiatives across the MCCCC enterprise focusing on: Black men (prostate cancer), Hispanic adults (colorectal and liver cancers), rural-residing adults (lung and colorectal cancers), and expansion to include Sexual and Gender Minority health. This extension will enable us to further assess the impact of multi- channel communication campaigns targeting Black, Hispanic, Rural, and Sexual and Gender Minority populations on cancer prevention, control, and survivorship (CaPCaS). The specific aims of this extension are to: (1) expand the implementation of culturally tailored multi-channel communication campaigns for targeted populations enterprise-wide; (2) foster continuous improvement of MICEO activities based on comprehensive evaluations focused on assessing the effectiveness of the campaigns; and (3) foster the dissemination, replicability and sustainability of the MCCCC MICEO initiatives through community and partnership engagements of local organizations, faith-based organizations. healthcare providers, and other educational institutions.

View original record on NIH RePORTER →
Mayo CCCG (Supp) - Impact of Multi-Channel Communication Campaigns on Cancer Prevention, Control and Survivorship (CaPCaS) in Black, Hispanic, Rural, and Sexual and Gender Minority Populations · GrantIndex